Nanjing Noratech Pharmaceuticals Co., Ltd.
Records under this name other than the patents Nanjing Noratech Pharmaceuticals Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 4 of 4 · Back to Nanjing Noratech Pharmaceuticals Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,080,746 | Donepezil Derivative and Use Thereof Lapsed on the fee record Ended Sep 25, 2026 · High confidence | Lapsed on the fee record | Ended Sep 25, 2026 | High confidence |
| US 10,745,363 | Crystal forms of valsartan disodium salt Lapsed on the fee record Ended Aug 18, 2024 · USPTO record | Lapsed on the fee record | Ended Aug 18, 2024 | USPTO record |
| US 10,683,260 | Crystalline form of sacubitril sodium salt Lapsed on the fee record Ended Jun 16, 2024 · USPTO record | Lapsed on the fee record | Ended Jun 16, 2024 | USPTO record |
| US 10,632,111 | Donepezil Derivative and Use Thereof Lapsed on the fee record Ended Apr 28, 2024 · Medium confidence | Lapsed on the fee record | Ended Apr 28, 2024 | Medium confidence |